FLT1 and breast cancer: Furthermore, antihuman VEGFR-1 mAB treatment increases the survival of mice injected with acute lymphoblastic leukaemia cells [29] and also inhibits tumour growth of VEGFR-1 positive breast cancer and melanoma xenografts [14].